RNO 0.00% 4.0¢ rhinomed limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

  1. 861 Posts.
    lightbulb Created with Sketch. 164
    What I really liked about this report was that the core health market provided over 60% of revenue and is still growing. So the swab end of the company is realy cream although I do expect that it will begin to dominate revenues going forward.
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.